Literature DB >> 19390193

Simultaneous occurrence of inflammatory bowel disease and myelodysplastic syndrome due to chromosomal abnormalities in bone marrow cells.

Fumiyasu Nakamura1, Tomohiro Watanabe, Kimiko Hori, Yoshiaki Ohara, Kouhei Yamashita, Yoshihisa Tsuji, Yoshihide Ueda, Sakae Mikami, Hiroshi Nakase, Tsutomu Chiba.   

Abstract

BACKGROUND/AIMS: Although chromosomal abnormalities in bone marrow (BM) cells, such as trisomy 8, are risk factors for the development of inflammatory bowel diseases (IBD) as well as myelodysplastic syndrome (MDS), the mechanisms of how these cytogenetic abnormalities cause intestinal inflammation are poorly understood. METHODS AND
RESULTS: A 55-year-old man with a 3-month history of watery diarrhea, fever and abdominal pain was admitted. Blood examinations revealed pancytopenia. Pathological analysis and endoscopic images of the entire colon led to the diagnosis of IBD of unclassified type. BM examination showed that the pancytopenia was due to MDS and that his BM cells had dual chromosomal abnormalities: 47, XY, +1, der(1;7)(q10;p10), +8. Immunological studies using peripheral blood monocytes from this patient revealed that the dual chromosomal abnormalities of BM cells led to the development of colitogenic monocytes producing a large amount of pro-inflammatory cytokines and showing resistance to apoptosis upon stimulation with microbial antigens.
CONCLUSION: An abnormal karyotype of BM cells is not only responsible for the development of MDS, but also for IBD in this case. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2009        PMID: 19390193     DOI: 10.1159/000213486

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  5 in total

1.  Multiple colonic ulcers associated with trisomy 8: serial changes in colonoscopic findings.

Authors:  Shunichi Yanai; Shotaro Nakamura; Keisuke Kawasaki; Shigeki Ito; Tamotsu Sugai; Takayuki Matsumoto
Journal:  Clin J Gastroenterol       Date:  2016-07-13

Review 2.  Deregulation of innate immune and inflammatory signaling in myelodysplastic syndromes.

Authors:  I Gañán-Gómez; Y Wei; D T Starczynowski; S Colla; H Yang; M Cabrero-Calvo; Z S Bohannan; A Verma; U Steidl; G Garcia-Manero
Journal:  Leukemia       Date:  2015-03-12       Impact factor: 11.528

Review 3.  Anemia in inflammatory bowel disease: a neglected issue with relevant effects.

Authors:  Danila Guagnozzi; Alfredo J Lucendo
Journal:  World J Gastroenterol       Date:  2014-04-07       Impact factor: 5.742

Review 4.  Treatment of Crohn's disease complicated with myelodysplastic syndrome via allogeneic hematopoietic stem cell transplantation: case report and literature review.

Authors:  Changmei Hu; Liang Lv; Deliang Liu; Jirong Huo
Journal:  Clin J Gastroenterol       Date:  2014-05-22

5.  Allogeneic hematopoietic stem cell transplantation for Crohn disease complicated with myelodysplastic syndrome: A case report.

Authors:  Ying Zhang; Li-Li Lou; Xiao-Dong Shi; Sha-Sha Lu; Li-Xia Zhang; Xu Huang; Hui-Fan Ji; Xu Li; Xiao-Lin Guo
Journal:  Medicine (Baltimore)       Date:  2020-03       Impact factor: 1.889

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.